Bayer acquires Chinese consumer co.
Bayer announced that it will buy China-based Dihon Pharmaceutical Group, a consumer-care company. The company is known for selling dandruff treatment Kang Wang and antifungal cream Pi Kang Wang.
"Adding the strong OTC brands from Dihon to our portfolio will significantly advance our business in China and positions us well for future growth," said Bayer Healthcare CEO Olivier Brandicourt.
Dihon employs more than 2,000 workers and operates a production and warehouse facility in Kunming.